Insider · CIK 0001207405

TYSON TIMOTHY

Reports to the SEC for 5 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001207405

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-05	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+4,000 sh	—	—	33,189
2024-06-05	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-06-01	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+4,000 sh	—	—	29,189
2023-06-01	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2022-09-30	Syros Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+14K sh	$6.37	+$89.2K	24,932
2022-09-29	Syros Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+2,932 sh	$5.72	+$16.8K	10,932
2022-09-16	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+8,000 sh	—	—	8,000
2022-09-16	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+257 sh	—	—	8,257
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+2,232 sh	—	—	2,232
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,094 sh	—	—	1,094
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+3,286 sh	—	—	3,286
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+2,191 sh	—	—	2,191
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+2,191 sh	—	—	2,191
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+2,848 sh	—	—	2,848
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+3,856 sh	—	—	3,856
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+3,856 sh	—	—	3,856
2022-09-16	TYME TECHNOLOGIES, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−5,865 sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−50.1K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−75K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−65K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−88K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−88K sh	—	—	0
2022-09-16	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+8,000 sh	—	—	8,000
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-08-24	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyA Award	Director	AAward	+88K sh	—	—	88,000
2021-08-24	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyA Award	Director	AAward	+88K sh	—	—	88,000
2020-08-20	TYME TECHNOLOGIES, INC.Director Stock Option - right to buyA Award	Director	AAward	+65K sh	—	—	65,000
2019-08-22	TYME TECHNOLOGIES, INC.Director Stock Option - right to buyA Award	Director	AAward	+50K sh	—	—	50,000
2018-11-14	Icagen, Inc.Stock OptionA Award	Director, 10% Owner	AAward	+25K sh	—	—	25,000
2018-11-14	Icagen, Inc.Stock OptionA Award	Director, 10% Owner	AAward	+100K sh	—	—	100,000
2018-08-26	TYME TECHNOLOGIES, INC.Director Stock Option - right to buyA Award	Director	AAward	+50K sh	—	—	50,000
2018-08-13	Icagen, Inc.WarrantA Award	Director, 10% Owner	AAward	+45K sh	—	—	45,000
2018-07-13	Icagen, Inc.Series C Convertible Preferred StockA Award	Director, 10% Owner	AAward	+114K sh	—	—	685,704
2018-07-13	Icagen, Inc.WarrantA Award	Director, 10% Owner	AAward	+114K sh	—	—	685,704
2018-05-24	TYME TECHNOLOGIES, INC.Director Stock Option - right to buyA Award	Director	AAward	+75K sh	—	—	75,000
2018-04-04	Icagen, Inc.Series C Convertible Preferred StockA Award	Director, 10% Owner	AAward	+571K sh	—	—	571,428
2018-04-04	Icagen, Inc.WarrantA Award	Director, 10% Owner	AAward	+571K sh	—	—	571,428
2017-12-29	Icagen, Inc.P Purchase	Director, 10% Owner	PPurchase	+21.4K sh	$0.37	+$7,928.36	164,284
2017-12-29	Icagen, Inc.WarrantA Award	Director, 10% Owner	AAward	+5,357 sh	$0.02	+$107.14	5,357
2017-11-22	TYME TECHNOLOGIES, INC.Director Stock Option - right to buyA Award	Director	AAward	+51K sh	—	—	50,958
2017-08-14	BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion	Director	MExercise/Conversion	+3,658 sh	—	—	4,658
2017-08-14	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,658 sh	—	—	3,657
2017-07-14	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitA Award	Director	AAward	+7,315 sh	—	—	7,315
2017-07-14	BIODELIVERY SCIENCES INTERNATIONAL INCStock OptionsA Award	Director	AAward	+3,658 sh	$2.64	+$9,657.12	3,658
2017-04-12	Icagen, Inc.WarrantA Award	Director, 10% Owner	AAward	+75K sh	—	—	75,000
2017-03-15	Icagen, Inc.Stock OptionA Award	Director, 10% Owner	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Jun 74
TYSON TIMOTHY0000950170-24-070714
SEC(opens sec.gov)
Jun 24
TYSON TIMOTHY0001209191-23-033732
SEC(opens sec.gov)
Apr 204/A
TYSON TIMOTHY0001209191-23-025002
SEC(opens sec.gov)
Oct 34
TYSON TIMOTHY0001209191-22-051854
SEC(opens sec.gov)
Sep 194
TYSON TIMOTHY0001209191-22-050558
SEC(opens sec.gov)
Sep 164
TYSON TIMOTHY0000899243-22-031351
SEC(opens sec.gov)

Companies

Address

C/O ONE KENDALL SQUARE, SUITE B2002

CAMBRIDGE, MA, 02139